ABBOTINDIA · Healthcare
The board meets on 5 Nov 2026 to approve the results. This page fills in when the numbers are filed.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,494 cr | ₹1,437 cr | ₹1,439 cr | ₹1,558 cr | ₹1,633 cr | ₹1,614 cr | ₹1,605 cr | ₹1,738 cr | ₹1,757 cr | ₹1,724 cr | ₹1,710 cr | ₹1,814 cr |
| YoY | — | — | — | +5% | +9% | +12% | +12% | +12% | +8% | +7% | +7% | +4% |
| EBITDA margin | 25.5% | 27.0% | 22.9% | 25.1% | 26.9% | 27.0% | 26.7% | 25.7% | 28.6% | 26.9% | 28.1% | 28.8% |
| Other income, % of PBT | 13% | 13% | 21% | 15% | 13% | 15% | 16% | 15% | 13% | 14% | 14% | 13% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 25% | 26% | 26% | 25% | 25% | 26% | 24% | 26% | 24% | 26% | 26% | 25% |
| Net profit | ₹313 cr | ₹311 cr | ₹287 cr | ₹328 cr | ₹359 cr | ₹361 cr | ₹367 cr | ₹366 cr | ₹415 cr | ₹376 cr | ₹395 cr | ₹429 cr |
| YoY | — | — | — | +13% | +15% | +16% | +28% | +12% | +16% | +4% | +8% | +17% |
| Core profit YoY | — | — | — | +11% | +17% | +14% | +32% | +14% | +14% | +6% | +12% | +18% |
| EPS | ₹147.27 | ₹146.35 | ₹135.09 | ₹154.36 | ₹168.76 | ₹169.78 | ₹172.73 | ₹172.18 | ₹195.43 | ₹176.93 | ₹185.86 | ₹201.66 |
| Flags | · | · | · | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.